Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes [1]

Clinical Chemistry

Volumn 51, Issue 9, 2005, Pages 1749-1750

  Challier, Marion ^a   Jacqueminet, Sophie ^a   Benabdesselam, Ouardia ^a   Grimaldi, André ^a   Beaudeux, Jean Louis ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; HEMOGLOBIN A1C;

ADULT; AGED; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PATHOGENESIS; PATHOPHYSIOLOGY; RETINOPATHY; SIGNAL TRANSDUCTION; SRAGE GENE; VASCULAR DISEASE;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; HUMANS; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; SOLUBILITY;

EID: 24144459068     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.051961     Document Type: Letter

References (7)

1. Ahmed N. Advanced glycation endproducts. Role in pathology of diabetic complications. Diabetes Res Clin Pract 2005;67:3-21.
2. Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J Pharmacol Sci 2005;97:305-11.
3. Stern DM, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 2002;1:1-15.
4. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, et al. Novel splice variants of the receptor for advanced glycation endproducts expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003;370:1097-109.
5. Massin P, Angioi-Duprez K, Bacin F, Cathelineau B, Cathelineau G, Chaine G, et al. Recommendations of the ALFEDIAM (French Association for the Study of Diabetes and Metabolic Diseases) for the screening and surveillance of diabetic retinopathy. J Fr Ophtalmol 1997;20: 302-10.
6. Aso Y, Inukai T, Tayama K, Takemura Y. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol 2000;37:87-92.
7. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 2005;25:1-6.